Sign in

CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
operating
EIN
112622630
Phone
408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Director bought 700 shares at an average $4.91 ($3,437)
  2. 4 Open-market buy Director bought 100 shares at $5.15 ($515)
  3. 4 Open-market buy Director bought 681 shares at an average $5.28 ($3,598)
  4. EFFECT Other Notice of Effectiveness
  5. 4 Open-market buy Director bought 600 shares at $5.62 ($3,372)
  6. 4 Open-market buy Director bought 500 shares at $4.90 ($2,450)
  7. 4 Open-market buy Director bought 300 shares at an average $5.29 ($1,588)
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. 4 Open-market buy Director bought 600 shares at an average $4.46 ($2,673)
  10. S-3/A Offering Registration Statement
  11. UPLOAD Other SEC-generated Letter
  12. 4 Open-market buy Director bought 2,000 shares at $3.95 ($7,900)
  13. S-3 Offering Registration Statement
  14. 8-K Event Shareholder vote results
  15. 4 Open-market buy Director bought 2,000 shares at $4.15 ($8,300)
  16. 10-Q Report Quarterly Report
  17. 4 Open-market buy Director bought 300 shares at $4.66 ($1,398)
  18. 4 Open-market buy Director bought 1,700 shares at $4.49 ($7,633)
  19. 4 Open-market buy Director bought 1,500 shares at $5.23 ($7,845)
  20. 4 Open-market buy Director bought 3,050 shares at an average $5.15 ($15,704)

Page 23 of 50 · 983 filings